Luis Peña

Luis Peña has more than 30 years of biotech and pharmaceutical experience with a proven track record of success in the global development of diverse products across multiple therapeutic areas. Luis is a strategic thinker focused on defining clear business objectives and instilling a sense of urgency for driving the success of companies ranging from startups to large, established pharmaceuticals. Luis has driven multiple project approvals of global programs across various therapeutic areas including dermatology, immunology, cardiology, and infectious disease. Luis was a cofounder of Dermira and served as a chief development officer, where he headed the R&D group. Prior to joining Dermira, Luis served as Vice President, Head of Global Prescription Development at Stiefel, a GSK company, and was senior vice president of portfolio planning and management at Stiefel Laboratories prior to its acquisition by GlaxoSmithKline, Inc. He also held leadership roles in portfolio management and product development at Connetics and Theravance, Inc., as well as various leadership positions in manufacturing and research and development at Genentech, Inc. Luis holds a BS in biochemistry from San Francisco State University.